Platelet function profiles in patients with diabetes mellitus.
作者： Fabiana Rollini , Francesco Franchi , Ana Muñiz-Lozano , Dominick J Angiolillo
DOI: 10.1007/S12265-013-9449-0
关键词:
摘要: … proportion of DM patients show inadequate response to standard antiplatelet treatments and high rate of adverse recurrent cardiovascular events despite compliance with standard …
springer.com
sci-hub.se 参考文章(182)
M Pinget, M L Wiesel, P Attali, L Kessler, J M Mossard, J P Cazenave, Von Willebrand factor in diabetic angiopathy. Diabetes & Metabolism. ,vol. 24, pp. 327- 336 ,(1998)
Young-Hoon Jeong, Seung-Whan Lee, Bong-Ryong Choi, In-Suk Kim, Myung-Ki Seo, Choong Hwan Kwak, Jin-Yong Hwang, Seong-Wook Park, Randomized Comparison of Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With High Post-Treatment Platelet Reactivity Results of the ACCEL-RESISTANCE (Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With Clopidogrel Resistance) Randomized Study Journal of the American College of Cardiology. ,vol. 53, pp. 1101- 1109 ,(2009) , 10.1016/J.JACC.2008.12.025
Dominick J. Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, Fernando Alfonso, Carlos Macaya, Theodore A. Bass, Marco A. Costa, Variability in Individual Responsiveness to Clopidogrel: Clinical Implications, Management, and Future Perspectives Journal of the American College of Cardiology. ,vol. 49, pp. 1505- 1516 ,(2007) , 10.1016/J.JACC.2006.11.044
Effects of intensive glucose lowering in type 2 diabetes The New England Journal of Medicine. ,vol. 358, pp. 2545- 2559 ,(2008) , 10.1056/NEJMOA0802743
Masafumi Ueno, José Luis Ferreiro, Bhaloo Desai, Salvatore D. Tomasello, Antonio Tello-Montoliu, Davide Capodanno, Piera Capranzano, Murali Kodali, Kodlipet Dharmashankar, Ronald K. Charlton, Theodore A. Bass, Dominick J. Angiolillo, Cigarette Smoking Is Associated With a Dose-Response Effect in Clopidogrel-Treated Patients With Diabetes Mellitus and Coronary Artery Disease JACC: Cardiovascular Interventions. ,vol. 5, pp. 293- 300 ,(2012) , 10.1016/J.JCIN.2011.09.027
Seung-Whan Lee, Seong-Wook Park, Young-Hak Kim, Sung-Cheol Yun, Duk-Woo Park, Cheol Whan Lee, Myeong-Ki Hong, Hyun-Sook Kim, Jae-Ki Ko, Jae-Hyeong Park, Jae-Hwan Lee, Si Wan Choi, In-Whan Seong, Yoon Haeng Cho, Nae-Hee Lee, June Hong Kim, Kook-Jin Chun, Seung-Jung Park, Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients With Diabetes Mellitus: The DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients) Journal of the American College of Cardiology. ,vol. 51, pp. 1181- 1187 ,(2008) , 10.1016/J.JACC.2007.11.049
Denis Clement, A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events(CAPRIE). The Lancet. ,vol. 348, pp. 1329- 1339 ,(1996)
AO Maree, RJ Curtin, A Chubb, C Dolan, D Cox, J O'brien, P Crean, DC Shields, DJ Fitzgerald, None, Cyclooxygenase‐1 haplotype modulates platelet response to aspirin Journal of Thrombosis and Haemostasis. ,vol. 3, pp. 2340- 2345 ,(2005) , 10.1111/J.1538-7836.2005.01555.X
Takeshi Nishikawa, Diane Edelstein, Xue Liang Du, Sho-ichi Yamagishi, Takeshi Matsumura, Yasufumi Kaneda, Mark A. Yorek, David Beebe, Peter J. Oates, Hans-Peter Hammes, Ida Giardino, Michael Brownlee, Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage Nature. ,vol. 404, pp. 787- 790 ,(2000) , 10.1038/35008121
P. FONTANA, P. ALBERTS, K. S. SAKARIASSEN, H. BOUNAMEAUX, J.-P. MEYER, A. SANTANA SORENSEN, The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin. Journal of Thrombosis and Haemostasis. ,vol. 9, pp. 2109- 2111 ,(2011) , 10.1111/J.1538-7836.2011.04446.X